What is the Impact Factor of Antiviral Therapy?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Antiviral Therapy is 3.30, ranking in quartile Q2 of Web of Science (SCIE).

Is Antiviral Therapy indexed in Web of Science or Scopus?

Yes, Antiviral Therapy is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.836 (Q2) and an H-index of 96.

Who publishes Antiviral Therapy and what is the Article Processing Charge (APC)?

Antiviral Therapy is published by International Medical Press Ltd. The estimated Article Processing Charge (APC) is approximately $3,067 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Antiviral Therapy?

The official ISO-4 abbreviation of Antiviral Therapy is "ANTIVIR THER". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q2SCImago #6,462Gold OA

Antiviral Therapy

Abbreviation (ISO):ANTIVIR THER

•

Identifier (ISSN):1359-6535(Print)/2040-2058(Online)

•

Publisher:International Medical Press Ltd

Official Website Submission Portal Compare

Clarivate IF (2026)

3.3↑ +1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Antiviral Therapy

WoS Q2

Annual Impact Factor Metric

Current (2026):3.3

Scopus SJR & RankScopus Q2

0.836

#6,462

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

96 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

17articles/year

100% Gold OA•76.32% Original Research

Aims & Scope

Antiviral Therapy (an official publication of the International Society of Antiviral Research) is an international, peer-reviewed journal devoted to publishing articles on the clinical development and use of antiviral agents and vaccines, and the treatment of all viral diseases. Antiviral Therapy is one of the leading journals in virology and infectious diseases. The journal is comprehensive, and publishes articles concerning all clinical aspects of antiviral therapy. It features editorials, original research papers, specially commissioned review articles, letters and book reviews. The journal is aimed at physicians and specialists interested in clinical and basic research.

Topics Covered (Recognized by AI)

Medicine99.5%Biology95.8%Immunology90.5%Virology89.9%Genetics88.7%Virus82%Internal medicine80%Family medicine67.1%Human immunodeficiency virus (HIV)66.9%Chemistry61.4%Biochemistry58.9%Viral load51.3%Gene44.4%Antiretroviral therapy42.9%Pathology42.1%Chronic hepatitis34.4%Viral disease31.1%Pharmacology29.8%Hepatitis B virus26.4%Surgery25.9%Gastroenterology25.8%Lamivudine21.4%Genotype21%

Primary Research Areas

Medicine Virology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

INFECTIOUS DISEASES

Rank53/141

IndexSCIE

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank149/356

IndexSCIE

JCRSCIE2026

VIROLOGY

Rank20/44

IndexSCIE

JCISCIE2026

INFECTIOUS DISEASES

Rank96/141

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank227/356

IndexSCIE

JCISCIE2026

VIROLOGY

Rank27/44

IndexSCIE

Category	Index	Rank	Quartile
INFECTIOUS DISEASES	JCRSCIE	53/141	Q2
PHARMACOLOGY & PHARMACY	JCRSCIE	149/356	Q2
VIROLOGY	JCRSCIE	20/44	Q2
INFECTIOUS DISEASES	JCISCIE	96/141	Q3
PHARMACOLOGY & PHARMACY	JCISCIE	227/356	Q3
VIROLOGY	JCISCIE	27/44	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.3

Articles / Year7

Total Citations0

2025

IF2.3

Articles / Year18

Total Citations30

2024

IF1.3

Articles / Year11

Total Citations50

2023

IF1.2

Articles / Year31

Total Citations255

2022

IF1.679

Articles / Year39

Total Citations319

Year	Impact Factor	Articles / Year	Total Citations
2026	3.3	7	0
2025	2.3	18	30
2024	1.3	11	50
2023	1.2	31	255
2022	1.679	39	319
2021	—	19	86
2020	2.043	5	69
2019	2.305	52	440
2018	2.146	86	866
2017	—	94	1,583
2016	—	96	1,513
2015	—	98	1,578

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,462Scopus Q2SCImago Profile

Scopus Coverage:1996-2025

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q2

0.836

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

3.34

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,067 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations194

3-Year Documents74

Citable Documents70

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate48.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Infectious DiseasesQ2

PharmacologyQ2

Pharmacology (medical)Q2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区INFECTIOUS DISEASES

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Antiviral Therapy (abbr: ANTIVIR THER, ISSN: 1359-6535) is a peer-reviewed international scholarly journal in the field of Medicine, published by International Medical Press Ltd in England since 1996. The periodical holds a Journal Impact Factor (JIF) of 3.30, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.836 (Q2), an H-index of 96.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 17 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,067 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.